EDITORIAL
Accepted on 27 Jan 2025
Editorial:Revealing the Role of Mitochondrial Gene Defects in Tumor Progression and Developing Mitochondrial-Targeted Drugs
doi 10.3389/fonc.2025.1553496
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Revealing the Role of Mitochondrial Gene Defects in Tumor Progression and Developing Mitochondrial-Targeted Drugs
Revealing the Role of Mitochondrial Gene Defects in Tumor Progression and Developing Mitochondrial-Targeted Drugs
2,398
Total downloads
8,668
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 04 Jul 2024
Mitochondrial inhibitors: a new horizon in breast cancer therapy
doi 10.3389/fphar.2024.1421905
- 1,027 views
- 2 citations
REVIEW
Published on 27 Jun 2024
Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker
doi 10.3389/fonc.2024.1394699
- 2,087 views
ORIGINAL RESEARCH
Published on 15 Dec 2023
Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma
doi 10.3389/fonc.2023.1276715
- 1,612 views
- 10 citations
REVIEW
Published on 30 Nov 2023
The development of cancers research based on mitochondrial heat shock protein 90
doi 10.3389/fonc.2023.1296456
- 1,912 views
- 4 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 8,668Topic views
- 5,484Article views
- 2,398Article downloads